Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Judge overturns Amgen’s $50m damages loss
Americas
Judge overturns Amgen’s $50m damages loss
A pair of patents behind an infringement case that proved expensive for Amgen have been found “unenforceable due to inequitable conduct”.   15 August 2025
Weil adds two more litigators from larger rival
Careers
Weil adds two more litigators from larger rival
The pair follow heads of tech and litigation out the door, bringing experience of representing clients before district courts, Federal Circuit, PTAB, and the ITC.   14 August 2025
Why the PTAB’s new expedited filing dates for AIA petitions is positive
Americas
Why the PTAB’s new expedited filing dates for AIA petitions is positive
A procedural change at the Patent Trial and Appeal Board offers petitioners a valuable tool to push back against Fintiv-based discretionary denial, writes Taylor Stemler of Merchant & Gould.   14 August 2025
Americas
Ninth Circuit revives trade secrets claims in DNA-sequencing spat
Plaintiff accuses defendant of “locking” employees out of office to steal secrets | Ruling rejects California’s stricter “reasonable particularity” rule for federal DTSA cases | Decision may shape plaintiffs’ choice of legal claims in future disputes in the state.   13 August 2025
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
Firm takes over Novartis in major patent litigation | Move follows rival firm's withdrawal after conflict-of-interest challenge | Latham team led by new hire from Cravath.   13 August 2025
Americas
Patent pollution: Emissions charter aims to clean up IP
A new charter aims to help decarbonise IP operations and contribute to the energy transition. Its founders—Fabrice Mattei of Rouse, and Simone Frattasi of Maersk—tell Sarah Speight how.   12 August 2025
Americas
Why Trump’s revenue-raising patent plan is riddled with problems
A patent fee structure being mooted in the US could hurt the innovation economy, especially in industries like biotech and pharma—and will face backlash from businesses, writes Paul Hunter of Foley.   12 August 2025
Americas
Harvard’s patent portfolio at risk as Trump turns up the pressure
Administration targets university’s federally funded research | Commerce Secretary warns of patent seizure under Bayh-Dole Act | Harvard given deadline to provide list of federally funded patents | Uncertainty continues across universities amid broader research cuts.   11 August 2025
Careers
Weil adds leaders from Latham to head up tech and life sciences
The trio bring experience in patent, trade secret, and commercial disputes across high tech, biotech, and life sciences, with two returning to Weil after more than a decade.   11 August 2025
Americas
$740M deal ends COVID-19 vaccine feud between CureVac and BioNTech
Payout and licensing deal grants US rights to COVID-19 and flu products | Agreement paves way for BioNTech’s $1.25 billion acquisition of CureVac.   8 August 2025